Paul Romness
Fortuna: 5 M $ al 31/05/2026
Fortuna: 5 M $ al 31/05/2026
Paul A. Romness is the founder of OS Therapies, Inc. since 2018, holding the title of Chairman, President & Chief Executive Officer.
Former positions include Director-State Government Affairs at Amgen, Inc. from 2005 to 2008, Vice President-Government Affairs & Public Policy at Boehringer Ingelheim GmbH from 2008 to 2014, and Principal at PR Strategies from 2005 to 2008.
Education includes an undergraduate degree from American University and a graduate degree from Milken Institute School of Public Health.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 22/01/2026 | 2.473.000 ( 5,55 % ) | 5 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| OS THERAPIES INCORPORATED | Director Ejecutivo | 12/04/2018 |
| Empresas | Cargo | Fin |
|---|---|---|
Boehringer Ingelheim GmbH
Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Manufactures and wholesales animal health & pharmaceutical products | Consejero General | 01/01/2014 |
| AMGEN INC. | Consejero General | 01/03/2008 |
PR Strategies | Corporate Officer/Principal | 01/03/2008 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 6 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Boehringer Ingelheim GmbH
Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Manufactures and wholesales animal health & pharmaceutical products | Health Technology |
American University
American University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Milken Institute School of Public Health
Milken Institute School of Public Health Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OS Therapies, Inc.
OS Therapies, Inc. BiotechnologyHealth Technology Operates as a clinical stage therapeutic company engages in development and commercialization of treatments for osteosarcoma | Health Technology |
PR Strategies |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.